Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19332726

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Jun 1
First author
Miller DS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Miller DS
      type
      Author
    2. name
      Blessing JA
      type
      Author
    3. name
      Krasner CN
      type
      Author
    4. name
      Mannel RS
      type
      Author
    5. name
      Hanjani P
      type
      Author
    6. name
      Pearl ML
      type
      Author
    7. name
      Waggoner SE
      type
      Author
    8. name
      Boardman CH
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Miller DS
      type
      Author
    2. name
      Blessing JA
      type
      Author
    3. name
      Krasner CN
      type
      Author
    4. name
      Mannel RS
      type
      Author
    5. name
      Hanjani P
      type
      Author
    6. name
      Pearl ML
      type
      Author
    7. name
      Waggoner SE
      type
      Author
    8. name
      Boardman CH
      type
      Author
    bibliography ids
    1. nci-bib-17d2e3fb8214c28bdc677455
    book metadata
    content sha256
    7aaa490dbf663952ca88984b6057838f31aa536317291157611827b59f9bcb17
    document type
    citation
    dois
    1. 10.1200/JCO.2008.19.2963
    electronic publication date
    display
    2009 Mar 30
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19332726
    immutable id
    pubmed:19332726@7aaa490dbf663952ca88984b6057838f31aa536317291157611827b59f9bcb17
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    16
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2686-91
    volume
    27
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19332726
      provenance
      batch id
      4f803f1a8e7b4f56d2f1
      provider
      NCBI PubMed ESummary
      record sha256
      f1ee18a1d1bc8f0f208367d86ee63c0566c88f70d187a13d5a6b8af1348c7a11
      response sha256
      fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
      retrieved at
      2026-09-09T23:46:26.391289+00:00
      publication date
      display
      2009 Jun 1
      precision
      day
      year
      2009
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19332726/
      title
      Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.

      Preserved source evidence · Not medical advice